This study aims to quantify the expression levels of the ESR1, HOTAIR, and miR-130a genes in serum samples obtained from Egyptian female breast cancer patients and examine the correlations between their expression levels and the clinicopathological features of the disease. This evidence concerns the gene ESR1 and breast carcinoma.